|
|
Thank You!
On behalf of everyone at G2 Intelligence, thank you for joining us, your colleagues, and our world-class faculty of molecular experts and laboratory business leaders in Boston as we unveiled a whole new focus for our 7th annual event: MDx NEXT.
We trust that our updated conference, aimed at providing insight into what’s happening now—and what’s next—for the rapidly growing area of molecular diagnostics, provided you with a wealth of valuable information, networking opportunities, and action items for your own lab.
Many thanks also to our distinguished speakers for taking time from their busy schedules to share their expertise and thoroughly cover every aspect of evolving MDx technologies, business challenges and opportunities, legal issues, day-to-day concerns, and attitudes toward molecular diagnostics as it becomes more widely applied by professionals—and more accessible to various consumer markets—than ever before.
Once again, thank you for being part of the Spring 2012 MDx NEXT molecular diagnostics conference, the must-attend event for:
- Lab Directors
- Medical Directors
- Lab Executives
- Pathologists
- Chief Technology Officers
- Procurement Specialists
- Information Technology Specialists
- Business Development Officers
- Chief Science Officers
- Informatics Specialists
Mark your calendars and save the date for our Fall MDx conference September 13-14 at the University Club of Chicago. More details to come!
|
Special thanks to our speakers:
Stafford O’Kelly
Lone Frank, Ph.D.
Kenneth Buetow, Ph.D.
Gyorgy Abel, M.D. Ph.D.
Sajo Beqaj, Ph.D., HCLD(ABB)
Jeremy Bridge-Cook, Ph.D.
Brenda Finucane, MS, CGC
Catherine Gebhart, Ph.D.
Dan Hyder, M.D.
David Jackson, Ph.D.
Jeffrey A. Kant, M.D., Ph.D., FCAP, FAAAS
Peter Kazon, Esq.
Jane M. Rachel, MT(ASCP), MA
Michele Schoonmaker, Ph.D.
Ted E. Schutzbank, Ph.D.
Rina Wolf
|